Affiliation:
1. Pirogov Russian National Research Medical University
2. G. N. Speransky Children Municipal Clinical Hospital no. 9
Abstract
Many hospitals use β-blockers in adult patients, however, their use in children has not yet been determined. The objective: to collect data on the use of β-blockers in children in intensive care units (ICU). Methods: an anonymous survey containing 17 questions regarding the use of β-blockers was distributed through social networks, messengers and email. The answers were compared with published data. Results. 48 respondents provided their replies. The survey has shown that 66.7% of them use β-blockers in children while 33.3% do not. Differences in the use of β-blockers in general and pediatric ICUs are statistically insignificant. Most clinics (50%) use β-blockers in patients with congenital heart defects, followed by sepsis (18.5%). Esmolol (34.4%) is the first-line drug, followed by propranolol (31.3%). The doses ranges vary significantly (excluding esmolol). Basic monitoring and echocardiography (40.6%) are most often used to monitor the use of β-blockers. Conclusion: The survey results have shown that in Russia, the use of β-blockers in children in ICU is very limited. It is necessary to conduct big randomized, multicenter, placebo-controlled studies that will determine the effectiveness of β-blockers in children in various clinical conditions.
Subject
Anesthesiology and Pain Medicine,Critical Care and Intensive Care Medicine,Emergency Medicine
Reference33 articles.
1. Аzovskiy D.K., Lekmanov А.U. The efficacy of the advanced monitoring in the acute phase of critical burns in children. Anesteziologiya i Reanimatologiya, 2019, no. 1, pp. 57-67. (In Russ.)
2. Аzovskiy D.K., Lekmanov А.U., Pilyutik S.F. Use of selective β1-atenolol blocker in children with severe thermal injury. Rossiyskiy. Vestnik detskoy khirurgii, anesteziologii i reanimatologii, 2016, no. 3 (6), pp. 73-80. (In Russ.)
3. Kozlov I.А. Pharmacological cardioprotection: what's new? Messenger of Anesthesiology and Resuscitation, 2019, no. 2 (16), pp. 57-66. (In Russ.)
4. Kucherov Yu.I., Zhirkova Yu.V., Rekhviashvili M.G. et al. Use of propanol for treating complicated hemangiomas in children. Pediatricheskaya Pharmocologiya, 2015, no. 4 (11), pp. 46-50. (In Russ.)
5. Agesen F.N., Weeke P.E., Tfelt-Hansen P. et al. Pharmacokinetic variability of beta-adrenergic blocking agents used in cardiology. Pharmacol. Res. Perspect., 2019, no. 4 (7), pp. 1-9.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献